OCT Variability Prevents Their Use as Robust Biomarkers in Multiple Sclerosis.

Although OCT is a valuable technology to improve MS patient assessment, differences between devices must be taken into account. It is necessary to create an international group that standardizes the measurement conditions and above all that provides reference bases for normal subjects.